Chaluvally-Raghavan, Pradeep, PhD

Pradeep Chaluvally-Raghavan, PhD

Assistant Professor

(414) 955-2573

Introduction

Dr. Pradeep Chaluvally-Raghavan received Ph.D. degree in 2006 from the University of Calicut, India where he focused on the role NF-kappa B activation and pro-inflammatory cytokine genes in melanoma models. After completion of graduate school, he moved to the laboratory of Dr. Yosef Yarden at the Weizmann Institute of Sciences, Israel for postdoctoral research. In Dr. Yarden’s laboratory, he studied the role of epidermal growth factor receptor (EGFR) family members in breast cancer progression.

Pradeep Chaluvally-Raghavan, PhD

During this period, he identified that NOTCH3 and NOTCH3-associated genes deregulate the growth of mammary epithelial cells and promote the transition of normal mammary duct to Ductal Carcinoma In Situ (DCIS) in breast cancer models. Further, during this transition phase of DCIS to invasive cancer, he characterized the role of three distinct pathways hypoxia, integrin and bone morphogenetic protein (BMP) signaling pathways. In 2010, he joined the lab of Dr. Gordon Mills in the Department of Systems Biology at the MD Anderson Cancer Center. In Mills lab, he focused on genomic aberrations such as gene mutation or copy number variation (CNVs), and its effect on downstream signaling pathways in breast and ovarian cancer. In 2016, he was recruited as a tenure track Assistant Professor to the Department of Obstetrics and Gynecology at the Medical College of Wisconsin. In the current position Dr. Chaluvally continues his post-doctoral work initiated in the Mills lab, and extends this research into other areas of non-coding RNA biology. Specifically, he is studying the role of non-coding RNA in mediating transcriptional and post-transcriptional regulation of gene expression. Over the last 6 years, he has made major scientific contributions to our understanding of the role of non-coding RNA aberrations as part of the CNVs in cancer.

Publications

Research

Principal InvestigatorTitle of Research Study
Awards / Publications / Presentations
Chaluvally-Raghavan, Pradeep, PhDTargeting miR511b to Prevent Tumor Formation and Metastasis of Triple Negative Breast Cancer
*Grant funded by Department of Defense (DoD)
Chaluvally-Raghavan, Pradeep, PhDUnexpected Role of CLDN11 ceRNA in Ovarian Cancer
*Grant funded by Ovarian Cancer Research Fund
Chaluvally-Raghavan, Pradeep, PhDRole of RNA Activation in Tumor Progression and Metastasis
*Grant funded by Froedtert Hospital Foundation (Cancer Center Seed Grant)
Chaluvally-Raghavan, Pradeep, PhDRNA Activation Driven Ovarian Cancer
*Grant funded by American Cancer Society - Cancer Center Seed Grant

In the News

Dr. Pradeep Chaluvally-Raghavan awarded American Cancer Society - Cancer Center Seed Grant on Unexpected Roles of microRNAs on Transcriptional Activation

Dr. Pradeep Chaluvally-Raghavan awarded American Cancer Society – Cancer Center Seed Grant on Unexpected Roles of microRNAs on Transcriptional Activation

Pradeep Chaluvally-Raghavan, PhD has been awarded an American Cancer Society – Cancer Center Seed Grant on “RNA Activation Driven Ovarian Cancer grant on Unexpected roles… Read More ›

Dr. Pradeep Chaluvally-Raghavan awarded DOD grant on Targeting miR551b to prevent Tumor formation and Metastasis of Triple Negative Breast Cancer

Dr. Pradeep Chaluvally-Raghavan awarded DOD grant on Targeting miR551b to prevent Tumor formation and Metastasis of Triple Negative Breast Cancer

Pradeep Chaluvally-Raghavan, PhD has been awarded a Department of Defense (DOD) grant on Targeting miR551b to prevent Tumor formation and Metastasis of Triple Negative Breast… Read More ›

Welcome Pradeep Chaluvally-Raghavan, PhD, Research Faculty

Welcome Pradeep Chaluvally-Raghavan, PhD, Research Faculty

06/24/2016  |  Department News

Dr. Pradeep Chaluvally-Raghavan, PhD

Dr. Chaluvally-Raghavan completed his Ph.D from the University of Calicut in India. During his graduate training his research… Read More ›

Lab

Chaluvally Lab

Chaluvally Lab

Copy number variations (CNVs) such as deletions or amplifications of chromosomal loci are common events during the initiation and progression of cancer. While…

Read More ›